• 26558 Citations
  • 78 h-Index
1982 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Gabriel Lopez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Author Correction: Hypoxia-mediated downregulation of miRNA biogenesis promotes tumour progression (Nature Communications, (2014), 5, 1, (5202), 10.1038/ncomms6202)

Rupaimoole, R., Wu, S., Pradeep, S., Ivan, C., Pecot, C. V., Gharpure, K. M., Nagaraja, A. S., Armaiz Pena, G. N., McGuire, M., Zand, B., Dalton, H. J., Filant, J., Miller, J. B., Lu, C., Sadaoui, N. C., Mangala, L. S., Taylor, M., van den Beucken, T., Koch, E., Rodriguez-Aguayo, C. & 9 others, Huang, L., Bar-Eli, M., Wouters, B. G., Radovich, M., Ivan, M., Calin, G. A., Zhang, W., Lopez-Berestein, G. & Sood, A. K., Dec 1 2020, In : Nature communications. 11, 1, 2867.

Research output: Contribution to journalComment/debate

Open Access
  • Blockade of cdk7 reverses endocrine therapy resistance in breast cancer

    Attia, Y. M., Shouman, S. A., Salama, S. A., Ivan, C., Elsayed, A. M., Amero, P., Rodriguez-Aguayo, C. & Lopez-Berestein, G., Apr 2 2020, In : International journal of molecular sciences. 21, 8, 2974.

    Research output: Contribution to journalArticle

    Open Access
  • Correction: Therapeutic targeting of Id2 reduces growth of human colorectal carcinoma in the murine liver (Oncogene, (2008), 27, 57, (7192-7200), 10.1038/onc.2008.356)

    Gray, M. J., Dallas, N. A., Van Buren, G., Xia, L., Yang, A. D., Somcio, R. J., Gaur, P., Mangala, L. S., Vivas-Mejia, P. E., Fan, F., Sanguino, A. M., Gallick, G. E., Lopez-Berestein, G., Sood, A. K. & Ellis, L. M., Jun 4 2020, In : Oncogene. 39, 23, 1 p.

    Research output: Contribution to journalComment/debate

    Open Access
  • Corrigendum to ‘Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancer’ [EBioMedicine 38 (2018) 100–112](S2352396418304973)(10.1016/j.ebiom.2018.11.004)

    Kanlikilicer, P., Bayraktar, R., Denizli, M., Rashed, M. H., Ivan, C., Aslan, B., Mitra, R., Karagoz, K., Bayraktar, E., Zhang, X., Rodriguez-Aguayo, C., El-Arabey, A. A., Kahraman, N., Baydogan, S., Ozkayar, O., Gatza, M. L., Ozpolat, B., Calin, G. A., Sood, A. K. & Lopez-Berestein, G., Feb 2020, In : EBioMedicine. 52, 102630.

    Research output: Contribution to journalComment/debate

    Open Access
  • GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma

    El-Arabey, A. A., Denizli, M., Kanlikilicer, P., Bayraktar, R., Ivan, C., Rashed, M., Kabil, N., Ozpolat, B., Calin, G. A., Salama, S. A., Abd-Allah, A. R., Sood, A. K. & Lopez-Berestein, G., Apr 2020, In : Cellular Signalling. 68, 109539.

    Research output: Contribution to journalArticle

    Open Access
  • 3 Scopus citations